Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-16.01M
↓ 175% below average
Average (7y)
$-5.82M
Historical baseline
Range
High:$-1.57M
Low:$-16.01M
CAGR
+39.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-16.01M | -71.7% |
| 2023 | $-9.33M | -16.0% |
| 2022 | $-8.04M | -74.9% |
| 2021 | $-4.60M | -146.7% |
| 2020 | $-1.86M | +45.6% |
| 2019 | $-3.43M | -102.7% |
| 2018 | $-1.69M | -7.4% |
| 2017 | $-1.57M | - |